middle.news
Atomo Opens New Growth Path With Gen 4 HIV Test Partnership
9:43am on Thursday 29th of October, 2026 AEDT
•
Healthcare
Read Story
Atomo Opens New Growth Path With Gen 4 HIV Test Partnership
9:43am on Thursday 29th of October, 2026 AEDT
Key Points
MOU launches Gen 4 HIV test development program
Innovation Scientific to conduct development, analytical and clinical studies
Atomo to manufacture the product and seek TGA and IVDR approval
Commercial launch targeted within 24 months
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Atomo Diagnostics (ASX:AT1)
OPEN ARTICLE